Boehringer Ingelheim's top prescription drugs 2023-2024

Published by
Matej Mikulic
,
Jul 10, 2025

In 2024, revenue of top product Jardiance (and familiar products) stood at approximately

***
billion euros. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany. This statistic shows revenues of Boehringer Ingelheim's top prescription drugs in 2023 and 2024.

Log in or register to access precise data.

Revenues of Boehringer Ingelheim's top prescription drugs in 2023 and 2024 (in million euros)

CharacteristicJardiance FamilyOfevTrajenta/JentaduetoSpirivaAcctilyse/Metalyse
- - - - - -
- - - - - -
Showing entries 1 to 2 (2 entries in total)
Statistic: Revenues of Boehringer Ingelheim's top prescription drugs in 2023 and 2024 (in million euros)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2025

Region

Worldwide, Germany

Survey time period

2023 and 2024

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Pharmaceutical market in ThailandDemographics of ThailandHealth in ThailandMedical device industry in ThailandCoronavirus (COVID-19) pandemic in Thailand
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.